ビジネス · 2008/6/31 分で読めます
Determination of Regulatory Review Period for Purposes of Patent Extension; TYZEKA; Correction
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 15, 2008 (73 FR 28119), announcing FDA's determination of the regulatory review period for TYZEKA. The document published with an incorrect docket number. This document corrects that error.